Navigation Links
CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
Date:5/5/2009

CARY, N.C., May 5 /PRNewswire/ -- ASG, Inc., saw continued growth in the first quarter following its acquisition of neighboring Ockham Development Group.

The February merger with the full-service contract research organization sought to expand the breadth and value of services that Cary, North Carolina-based ASG provides clients requiring functional outsourcing and staffing services or the opportunity to outsource an entire clinical trial.

ASG's CEO Jim Baker said, "I am pleased to announce that we continue to make progress in merging the two companies into one."

Through Ockham, ASG has secured new work in the therapeutic areas of oncology, anti-infectives, and vaccines. Ockham has picked up some "significant new business in the last month, and the emerging-growth biotech and pharma market seems to be picking up steam as we move into Q2," Baker said.

In the meantime, Baker indicated that ASG is "answering more functional outsourcing RFPs" and has recently won outsourcing work with one of the company's larger clients.

He also noted a staffing headcount increase over the past 45 days.

In completing the acquisition, ASG's global growth strategy will allow the firm to provide solutions that best meet the needs of existing and potential clients. At the same time, the acquisition will make it possible for Ockham - which will continue to be independently branded - to serve a wider and larger client base.

About ASG:

ASG is a global clinical research service provider of high-quality Contract Research, Functional Outsourcing, and Specialty Staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. Strategically organized to meet the demands of the marketplace, ASG provides flexible solutions that satisfy client needs through highly experienced recruiting and dedicated functional support teams located throughout the world. Staffed by veteran industry professionals with a track record of proven results, it is centrally located near the university-technology-biotech/pharmaceutical sciences nexus known internationally as Research Triangle Park (RTP). http://www.asg-inc.com


'/>"/>
SOURCE ASG, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
4. NxStage Medical Provides Update on Medisystems Acquisition
5. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
6. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
7. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
8. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
9. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
10. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
11. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed ... both viscous and elastic characteristics when deformed, which is identical to how the ... gently absorb compressive forces and return to its natural state along a hysteresis ...
(Date:3/23/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Global Market for Bioproducts Should ... at a CAGR of 8.9%, This research ... into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs ...
(Date:3/23/2017)... 2017  SeraCare Life Sciences, Inc., a manufacturer ... diagnostics manufacturers and clinical laboratories, is announcing ... Inherited Cancer reference material for ... sequencing (NGS). The Seraseq™ Inherited Cancer DNA Mix ... industry experts to validate the ability of ...
(Date:3/23/2017)... Calif., March 23, 2017  BioPharmX Corporation (NYSE ... for the dermatology market, today reported financial results ... 2017, and will provide an update on the ... year. "We are pleased to report ... for BioPharmX," said President Anja Krammer. "We achieved ...
Breaking Biology Technology:
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
Breaking Biology News(10 mins):